CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

JPMorgan Adjusts Price Target on Gilead Sciences to $170 From $160

Positive
AI Analysis

Summary

JPMorgan raised its price target on Gilead Sciences from $160 to $170 per share.

Importance:2/10
Sentiment:
0.30
price_targetanalyst_upgrade
Related Companies

Read the original article

Published by yahoo_finance on October 7, 2026 12:46 PM

Read Original